Journal Of Bone Oncology

Journal Title：Journal Of Bone Oncology

The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.

As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.

The areas covered by the journal include:

Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)

Preclinical models of metastasis

Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)

Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)

Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)

Bone imaging (clinical and animal, skeletal interventional radiology)

Bone biomarkers (clinical and translational applications)

Radiotherapy and radio-isotopes

Skeletal complications

Bone pain (mechanisms and management)

Orthopaedic cancer surgery

Primary bone tumours

Clinical guidelines

Multidisciplinary care

Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.

Journal of Bone Oncology 是一份经过同行评审的国际期刊，旨在展示与骨骼和癌症相关的基础、转化和临床高质量研究。

作为第一个致力于癌症诱发的骨病的期刊，JBO 欢迎原创研究文章、评论文章、社论和评论文章。只有在特殊情况下并且只有在对主题进行全面审查时才会考虑案例报告。

期刊涵盖的领域包括：

骨转移（病理生理学、流行病学、诊断、临床特征、预防、治疗）

转移的临床前模型

癌症中的骨微环境（干细胞、骨细胞和癌症相互作用）

骨靶向治疗（药理学、治疗靶点、药物开发、临床试验、副作用、结果研究、健康经济学）

癌症治疗引起的骨质流失（流行病学、病理生理学、预防和管理）

骨成像（临床和动物、骨骼介入放射学）

骨生物标志物（临床和转化应用）

放射治疗和放射性同位素

骨骼并发症

骨痛（机制和管理）

骨科癌症手术

原发性骨肿瘤

临床指南

多学科护理

关键词：双膦酸盐、骨、乳腺癌、癌症、CTIBL、地诺塞麦、转移瘤、骨髓瘤、成骨细胞、破骨细胞、骨肿瘤学、骨肿瘤学、前列腺癌、骨骼、肿瘤。

Journal Of Bone Oncology由ELSEVIER出版商出版，收稿方向涵盖Medicine - Oncology全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度20 Weeks，影响因子指数3.066，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。